Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Amarin Corp Ads (AMRN)

4.6   0.12 (2.68%) 11-27 01:11
Open: 4.4777 Pre. Close: 4.48
High: 4.68 Low: 4.46
Volume: 6,525,110 Market Cap: 1,789M
Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing REDUCE-IT for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company sells its products principally to wholesalers and specialty pharmacy providers through direct sales force. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.686 - 4.703 4.703 - 4.717
Low: 4.414 - 4.436 4.436 - 4.453
Close: 4.567 - 4.601 4.601 - 4.628

Technical analysis

as of: 2020-11-25 4:35:29 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 6.06     One year: 7.08
Support: Support1: 4.43    Support2: 3.96
Resistance: Resistance1: 5.19    Resistance2: 6.06
Pivot: 4.39
Moving Average: MA(5): 4.54     MA(20): 4.53
MA(100): 5.45     MA(250): 9.99
MACD: MACD(12,26): -0.07     Signal(9): -0.11
Stochastic oscillator: %K(14,3): 47.96     %D(3): 46.88
RSI: RSI(14): 50.44
52-week: High: 26.12  Low: 3.36  Change(%): -78.4
Average Vol(K): 3-Month: 936557  10-Days: 1025701

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AMRN has closed below upper band by 23.4%. Bollinger Bands are 46.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to AMRN's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 05 Oct 2020
ROCE Insights For Amarin Corp - Yahoo Finance

Fri, 11 Sep 2020
Amarin (AMRN): Vascepa’s International Opportunity Remains Intact, Says Analyst - Yahoo Finance

Thu, 03 Sep 2020
Amarin (AMRN) Bears the Brunt of a Price Target Cut - Yahoo Finance

Thu, 27 Aug 2020
Amarin (AMRN) in Focus: Stock Moves 5.5% Higher - Yahoo Finance

Wed, 05 Aug 2020
Amarin (AMRN) Beats on Q2 Earnings, Focuses on Europe - Yahoo Finance

Thu, 18 Jun 2020
Amarin (AMRN) Stock Will Likely Stay Range-Bound Near-Term, Says Analyst - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 389
Shares Float (M) 347
% Held by Insiders 1.03
% Held by Institutions 42.69
Shares Short (K) 23,780
Shares Short P. Month (K) 24,860

Stock Financials

EPS -0.044
EPS Est This Year -0.210
EPS Est Next Year -0.060
Book Value (p.s.) 1.550
Profit Margin -2.69
Operating Margin -3.61
Return on Assets (ttm) -1.5
Return on Equity (ttm) -2.6
Qtrly Rev. Growth 39.2
Gross Profit (p.s.) 0.858
Sales Per Share 1.518
EBITDA (p.s.) -0.050
Qtrly Earnings Growth
Operating Cash Flow (M) 8
Levered Free Cash Flow (M) 14

Stock Valuations

PE Ratio -104.55
PEG Ratio
Price to Book value 2.97
Price to Sales 3.03
Price to Cash Flow 234.11

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.